Citra Borneo Utama Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp790 (market cap 2.48T, 78.9K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 14.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 78.9K). Which is the better fit depends on your goals.
| CBUT | OBAT | |
|---|---|---|
Market Cap | 2.48T | 167.37B |
Volume | 78.9K | 96.7K |
Lot | 789 | 967 |
Turnover | 62.54M | 23.82M |
Average Price | 792.66 | 246.34 |
Value | 62.54M | 23.82M |
Indicative Equilibrium Price | 790 | 248 |
Indicative Equilibrium Volume | 1 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.
Read more on CBUT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →